<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.135540.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Effect of epigallocatechin gallate nanoemulsion on submandibular salivary glands following application of botulinum neurotoxins in albino rats: potential therapeutic effects</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Wahba</surname>
                        <given-names>Omneya</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Elhelbawy</surname>
                        <given-names>Nahla Gamaeldin</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>El-Borady</surname>
                        <given-names>Ola M.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Labah</surname>
                        <given-names>Doaa Ahmed</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Essa</surname>
                        <given-names>Ahmed Abdelaziz Mohamed</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-3675-1319</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a6">6</xref>
                    <xref ref-type="aff" rid="a7">7</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Assistant Professor, Pathologist, Department of Oral Pathology, Faculty of Dental &amp; Oral Medicine, Kafr El-shiekh University, Kafr El-shiekh, Egypt</aff>
                <aff id="a2">
                    <label>2</label>Professor, Dental Biomaterial Department, Faculty of Dentistry, Tanta University, Tanta, Egypt</aff>
                <aff id="a3">
                    <label>3</label>Department of Restorative Dentistry, College of Dentistry, Taibah University, Madinah Al Munawwarah, Saudi Arabia</aff>
                <aff id="a4">
                    <label>4</label>Professor, Nanoscience Department, Institute of Nanoscience and Nanotechnology, Kafr el-Sheikh University, Kafr El-Shaikh, Egypt</aff>
                <aff id="a5">
                    <label>5</label>Professor, Oral Biology Department, Faculty of Dentistry, Zagazig University, Zagazig, Egypt</aff>
                <aff id="a6">
                    <label>6</label>Assistant Professor of Oral Pathology, Department of Biomedical and Dental Sciences, Faculty of Dentistry, Al Baha University, Al Bahah, Saudi Arabia</aff>
                <aff id="a7">
                    <label>7</label>Assistant Professor, Oral pathology Department, Faculty of Dentistry, Tanta University, Tanta, Egypt</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:drahmedeissa1900@gmail.com">drahmedeissa1900@gmail.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>25</day>
                <month>9</month>
                <year>2023</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2023</year>
            </pub-date>
            <volume>12</volume>
            <elocation-id>1191</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>8</day>
                    <month>8</month>
                    <year>2023</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Wahba O et al.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/12-1191/pdf"/>
            <abstract>
                <p>
                    <bold>Background:</bold> Injecting botulinum neurotoxin (BoNT) into the salivary glands is a common treatment for certain diseases. Green tea&#x2019;s active compound, epigallocatechin-3-gallate (EGCG), has been linked to a variety of health benefits, including the reduction of free radicals and inflammation. This study compared the effects of BoNT and BoNT/EGCG on the submandibular salivary glands (SMG) histology and ultrastructure.</p>
                <p>
                    <bold>Methods:</bold> Both BoNT and BoNT/EGCG nanoemulsions were injected into the submandibular salivary glands (SMGs) in adult male albino rats, which were then euthanized, and the right SMGs were thoroughly dissected and prepared for histological, immunohistochemical, and transmission electron microscopic analysis.</p>
                <p>
                    <bold>Results:</bold> When compared to the BoNT group, the BoNT/EGCG nanoemulsion group significantly improved SMG acinar and ductal cells using both H&amp;E and immunohistochemical stainings. Ultrastructural findings of the BoNT/EGCG nanoemulsion group revealed marked improvement in the SMG structure, almost normal acini, and striated ducts.</p>
                <p>
                    <bold>Conclusion:</bold> Salivary gland histological structures are significantly altered after BoNT administration, but the addition of EGCG causes only minor alterations and can be used to treat hyperfunction.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>EGCG; Nanoemulsion; Botulinum Neurotoxins; BoNT; salivary; hyperfunction</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>One of the most potent natural toxins ever discovered by humans is botox, also known as botulinum neurotoxins (BoNTs). Various spore-forming anaerobic Clostridium botulinum strains produce seven BoNT serotypes (A&#x2013;G) (
                <xref ref-type="bibr" rid="ref1">Pirazzini 
                    <italic toggle="yes">et al.</italic>, 2017</xref>). BoNTs, or metalloproteinases, inhibit neurotransmitter 
                <xref ref-type="bibr" rid="ref15">Sherif 
                    <italic toggle="yes">et al.</italic> (2018)</xref> release at peripheral cholinergic nerve terminals by cleaving one or more core proteins of the neuroexocytosis apparatus. These substances have demonstrated efficacy in treating a variety of human syndromes brought on by excessively active cholinergic nerve terminals due to their focused mechanism of action. BoNT/A is also a pharmaco-cosmetic, and its clinical uses are expanding. Parkinson&#x2019;s disease, head and neck cancer, stroke, neurodegenerative disease, focal dystonia, spasticity, and other focal muscle hyperactivity conditions are treated with BoNT/A. Focal hyperhidrosis (axillary perspiration, palmer perspiration, or gustative perspiration), sialorrhea, pathological lacrimation, and rhinorrhea are some of the autonomous hypersecretory alterations that have been significantly affected by this discovery (
                <xref ref-type="bibr" rid="ref2">Thenganatt &amp; Fahn, 2012</xref>).</p>
            <p>Drooling in children with central nervous system disorders is often treated with BoNT salivary gland injections. Most patients experience a reduction in saliva production and drooling after receiving an intratglandular injection of BoNT because this treatment blocks acetylcholine release at nerve terminals. Even though BoNT can impair oral motor functions such as swallowing, eating, drinking, and articulation and cause sore throats, dry mouths, and teeth grinding, it is increasingly used to treat drooling (
                <xref ref-type="bibr" rid="ref3">Karen 
                    <italic toggle="yes">et al.</italic>, 2017</xref>). Additionally, BoNT&#x2019;s safety and effectiveness have their limits. Drooling can be controlled with BoNT, but it has some undesirable side effects that need to be addressed with an adjunctive therapy for optimal effectiveness (
                <xref ref-type="bibr" rid="ref4">Chan 
                    <italic toggle="yes">et al.</italic>, 2013</xref>).</p>
            <p>Green tea is made from Camellia sinensis leaves. According to recent research, drinking green tea may have important health benefits. According to studies, green tea has chemopreventive, antimicrobial, antiviral, antioxidant, anti-inflammatory, anti-proliferative, and anti-mutagenic properties (
                <xref ref-type="bibr" rid="ref5">Jayakeerthana, 2016</xref>). Additionally, it protects neurons, lowers the risk of cardiovascular disease, boosts bone health, and regulates metabolic processes like glucose, cholesterol, blood pressure, and body weight. Green tea&#x2019;s health benefits come from over 75% of its polyphenol compounds, including catechins. Catechins, one of the most important components of tea leaves, are thought to reduce the formation of free radicals in the body and protect cells from damage because of their intense antioxidant and representative physiological activities. In addition to contributing to the aging process, these free radicals have been linked to numerous diseases (
                <xref ref-type="bibr" rid="ref6">Bae 
                    <italic toggle="yes">et al.</italic>, 2020</xref>).</p>
            <p>Green tea contains 65% catechins, with EGCG (epigallocatechin gallate) being the most abundant and therapeutically effective. Among the catechins found in green tea, EGCG has the highest antioxidant capacity.
                <sup>(16)</sup> EGCG is used to prevent and treat many diseases, including cancer, metabolic syndrome, Parkinson&#x2019;s disease, Alzheimer&#x2019;s disease, obesity, and cardiovascular diseases. This makes using this natural substance for these applications a popular choice. The two main drawbacks that regrettably prevent the use of EGCG as a preventative or therapeutic agent are its inability to be absorbed by intestinal cells and its inherent instability (
                <xref ref-type="bibr" rid="ref7">Musial 
                    <italic toggle="yes">et al.</italic>, 2020</xref>).</p>
            <p>An approach that has been taken to address these deficiencies is the utilization of nanoencapsulated EGCG. The incorporation of EGCG into nanocarriers possesses the potential to increase the permeability of the intestinal barrier, which, in turn, results in the compound&#x2019;s increased stability and increased therapeutic efficacy. This is because the increased permeability of the intestinal barrier allows more nutrients to pass through (
                <xref ref-type="bibr" rid="ref8">Legeay 
                    <italic toggle="yes">et al.,</italic> 2015</xref>). Nanoemulsion delivers EGCG well due to its ease of preparation and industrialization. Because it possesses both advantages, this is the reason for this fact. Encapsulating EGCG in a nanoemulsion increases its bioavailability, stability, and biological activity (
                <xref ref-type="bibr" rid="ref9">Eng 
                    <italic toggle="yes">et al.,</italic> 2018</xref>).</p>
            <p>Nanoemulsions improve the bioavailability, stability, and biological activity of EGCG. This increases compound solubility. Because of this, a study was conducted to determine how intraglandular injection of BoNT affects the structure of rats&#x2019; SMG and how EGCG nanoemulsion reduces this effect.</p>
        </sec>
        <sec id="sec2" sec-type="methods">
            <title>Methods</title>
            <sec id="sec3">
                <title>Fabrication of EGCG nanoemulsion</title>
                <p>
                    <bold>Materials</bold>
                </p>
                <p>Sigma Aldrich Company (St. Louis,USA) provided the EGCG. Tween 80 (ADWIC, Egypt). Absolute ethanol (99.5&#x2013;99.8%) was purchased from Merck. For the immunohistochemical analysis of cell apoptosis and epithelial cell-to-cell adhesion, Dako (Glostrup, Denmark) supplied mouse monoclonal antibodies against human Bcl-2 (JC70A, IgG1) and E-cadherin (1A4, IgG2a).</p>
            </sec>
            <sec id="sec4">
                <title>Preparation of EGCG nanoemulsion</title>
                <p>EGCG nanoemulsion was prepared by a modified oil-in-water (O/W) emulsification method referring to (
                    <xref ref-type="bibr" rid="ref10">Gadkari 
                        <italic toggle="yes">et al.</italic>, 2017</xref>) using Tween 80 as an emulsifier. To get an O/W nanoemulsion, the prepared ethanolic solution containing EGCG was added drop-wise over a beaker containing 100 ml distilled water and homogenized via probe ultrasonicator (20,000 Hz) for 20 min under an ice bath. Firstly, 100 mg of EGCG was dissolved in 10 ml of ethanol then 0.01 gm of Tween 80 was added over it and mixed very well. The mixture was then stirred to get out the organic solvent (ethanol) with a magnetic stirrer (2,000 rpm) for 4 hours at room temperature. The obtained nanoemulsion was stored in the refrigerator for further use.</p>
            </sec>
            <sec id="sec5">
                <title>Characterization techniques of EGCG nanoemulsion</title>
                <p>Using a high-resolution transmission electron microscope (TEM) from Japan (JOEL JEM-2010) that operated at an accelerating voltage of 200 kV, the morphology and size of the nanoemulsion were examined. The Fourier transform infrared (FTIR) technique was utilised to carry out the spectral analysis of the nanoemulsion. Spectroscopy was performed using a JASCO spectrometer, Japan, and the scan ranged from 4000&#x2013;400 cm
                    <sup>&#x2212;1</sup>. To measure the surface charge of nanoemulsion and its average size, a zeta analyzer (Zetasizer Nano ZS Malvern) was used to investigate the zeta potential and size distribution.</p>
            </sec>
            <sec id="sec6">
                <title>EGCG nanoemulsion characterization</title>
                <p>
                    <bold>
                        <italic toggle="yes">Morphological analysis</italic>
                    </bold>
                </p>
                <p>Using a transmission electron microscope, an examination of the size and shape of the EGCG nanoemulsion that had been manufactured revealed the formation of a spherical nanoemulsion that possessed a high degree of homogeneity in shape. Around 130 nanometers was the average size of the particles that were developed (
                    <xref ref-type="fig" rid="f1">Figure 1A</xref>).</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Photographs demonstrate morphological and structural characterization of the synthesized EGCG nanoemulsion.</title>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/148664/18b75490-a2e8-42a3-a2c7-30953507a647_figure1.gif"/>
                </fig>
                <p>
                    <bold>
                        <italic toggle="yes">Size distribution and Zeta potential</italic>
                    </bold>
                </p>
                <p>When determining the colloidal stability and surface charges of the particles, the measurement of the zeta potential is considered. The fact that the Zeta potential of the prepared EGCG nanoemulsion was found to be negative 13.5 mV demonstrates the successful formation of a nanoemulsion (
                    <xref ref-type="fig" rid="f1">Figure 1B</xref>). The size distribution as well as the polydispersity index (PDI) for the EGCG nanoemulsion as measured by DLS. The measurements detect the size distribution to be 228 nm with PDI =1 (
                    <xref ref-type="fig" rid="f1">Figure 1C</xref>).</p>
                <p>
                    <bold>
                        <italic toggle="yes">The Fourier transformed infrared spectroscopy (FTIR)</italic>
                    </bold>
                </p>
                <p>The FTIR spectrum of original EGCG displayed a broad peak in the range of 3500-3300 cm
                    <sup>&#x2212;1</sup> attributed to the eight OH groups present in its structure. The presence of a fingerprint peak in the EGCG FTIR spectrum at 3357.46 cm
                    <sup>&#x2212;1</sup> referred to OH groups directly attached to the aromatic ring. Additionally, the EGCG IR spectrum revealed the presence of other bands at 1692 cm
                    <sup>&#x2212;1</sup>, 1616 and 1149 cm
                    <sup>&#x2212;1</sup> due to vibrations of C=O, C-C (aromatic ring), and C-O bonds (pyranose heterocyclic chain), respectively. Other bands were detected at 1235 cm
                    <sup>-1</sup> for the O-C=O group and 1035 cm
                    <sup>-1</sup> for the C-O-C group. On the other hand, the EGCG nanoemulsion showed the peaks corresponding to the OH, C=O, C-C (aromatic ring), and C-O bonds, O-C=O group and C-O-C group at 3367 cm
                    <sup>&#x2212;1</sup>, 1692 cm
                    <sup>&#x2212;1</sup>, 1621 cm
                    <sup>&#x2212;1</sup>, 1140 cm
                    <sup>&#x2212;1</sup>, 1243 cm
                    <sup>&#x2212;1</sup>, and 1028 cm
                    <sup>&#x2212;1</sup>, respectively. The shift observed in the EGCG nanoemulsion peak compared to than the original EGCG confirms its change to the nano form (
                    <xref ref-type="fig" rid="f1">Figure 1D</xref>).</p>
            </sec>
            <sec id="sec7">
                <title>Animals</title>
                <p>This study made use of thirty adult male albino rats, each of which weighed between 150 and 180 grammes on average
                    <bold>
                        <italic toggle="yes">.</italic>
                    </bold> An earlier method developed by Charan and Biswas was used in the computation of the estimation of the sample size. Five rats in each cage were housed in polycarbonate cages with wire lids at Zagazig University&#x2019;s Faculty of Medicine. Each cage was numbered, and the rats were kept in a well-ventilated animal house. A normal photoperiod was maintained while the room temperature was kept at 23 degrees Celsius and the humidity was kept at 60 percent. The rats were provided with a dry diet of rat pellets, and they had unrestricted access to water throughout the experiment. After an adjustment period of one week, the rats were randomized into three separate groups of equivalent size: Group I rats were a negative control for other groups. Group II (BoNT) rats were anesthetized by intramuscular injection of xylazine (6 mg/kg) (Sigma-Aldrich, USA) and ketamine (70 mg/kg) (Hospira, USA). The SMG was exposed via surgical incision, and then 5 units of BoNTA (Botox
                    <sup>&#x00ae;</sup>, Allergan Inc., Irvine, CA, USA) diluted in 0.1 ml saline were injected once at the center of the right SMG 
                    <sup>(24)</sup>. Group III (BoNT + EGCG nanoemulsion group) rats were anesthetized then the SMG was exposed, and BoNTA was injected at the center of the right SMG, similar to group II. Then, the rats received EGCG nanoemulsions in a once-daily dose of 0.1&#x2009;ml by oro-gastric intubation (
                    <xref ref-type="bibr" rid="ref11">Koutelidakis 
                        <italic toggle="yes">et al.</italic>, 2017</xref>). The first oral dose of EGCG nanoemulsions was given on the day of intraglandular BoNTA injection and continued daily for four weeks.</p>
                <p>All animal experiments followed ARRIVE&#x2019;s guidelines and the National Institutes of Health&#x2019;s lab animal protocol (NIH Publications, revised 1985). The Zagazig University Institutional Animal Care and Use Committee (ZU-IACUC/3/F/368/2022) approved animal care and experimental protocols.</p>
            </sec>
            <sec id="sec8">
                <title>Rat euthanasia</title>
                <p>Each rat was euthanized at the end of the experiment using a sodium thiopental overdose (EIPICO, Egypt), which was then followed by cervical dislocation. Five samples from each group were prepared for histological and immunohistochemical analysis after carefully dissecting the appropriate SMGs. The remaining five samples from each group were processed for transmission electron microscopy analysis.</p>
            </sec>
            <sec id="sec9">
                <title>Histological examination</title>
                <p>The SMG specimens were first fixed in a formalin solution buffered at 4%, followed by a series of increasing concentrations of ethanol used to dehydrate the glands. Finally, the entire gland was then embedded in paraffin. H&amp;E was used to stain sections that represented the entire sample, which were cut into five micrometer sections. At the Zagazig University Faculty of Medicine, a digital color CCD camera examined and photographed the slides (Olympus, DP73, Tokyo, Japan). A light microscope held it (Olympus BX53, Tokyo, Japan).</p>
            </sec>
            <sec id="sec10">
                <title>Immunohistochemical analysis</title>
                <p>Each paraffin block was divided into sections with a thickness of 4 micrometers for immunohistochemical staining. These sections were deparaffinized in xylene and dehydrated in increasing alcohol concentrations. To inhibit internal peroxidase activity, they were submerged in 3% hydrogen peroxide in PBS. Antigen retrieval was carried out in a Panasonic 1380-watt microwave oven for 10 minutes at 2 atm and 120&#x00b0;C. Further incubations with prediluted, ready-to-use primary mouse monoclonal antibodies (anti-Bcl-2, clone MIB-5; Sigma-Aldrich, USA, and anti-E-cadherin; clone HECD-1, Biocare Medical, USA) were used as the primary antibody for 30 min and was incubated in a moist chamber at room temperature (24 h) with a working dilution of 1:50 and 1:100, respectively, followed by the application of secondary antibody (for 15 min), DAB (to produce brown staining), and Meyer&#x2019;s hematoxylin (for background staining). Following each step mentioned, the samples were put into PBS. According to the manufacturer&#x2019;s instructions, the positive controls for Bcl-2 and E-cadherin were the kidney and skin, respectively. PBS was used in place of the primary antibody to create the negative control. Brown-colored reaction concentrated in the cytoplasm or nucleus was regarded as a positive reaction. In a blinded analysis carried out by two skilled research associates using a traditional light microscope and Image J software (version 4.10.03, Nikon, Tokyo, Japan), the intensity of the immunostaining was categorized as being negative, weak, moderate, or strong in three fields.</p>
            </sec>
            <sec id="sec11">
                <title>Transmission electron microscopic examination</title>
                <p>For two hours at room temperature, the 1 mm cubes of SMGs were submerged in a solution of 4 percent paraformaldehyde and 1 percent glutaraldehyde. Before being postfixed in osmium tetroxide at a concentration of 1%, the samples underwent one last rinse in buffer. Following the fixation procedure, the samples were dehydrated in increasing grades of ethanol, immersed in absolute acetone, and then embedded in Epon. At the Mansoura University Electron Microscopy Unit, the RMC-USA ultramicrotome was used to cut the ultrathin slices, then placed on copper grids, stained with uranyl acetate and lead citrate, and viewed with a JEOL JEM-2100 transmission electron microscope (Jeol Ltd, Tokyo, Japan).</p>
            </sec>
            <sec id="sec12">
                <title>Statistical analysis</title>
                <p>Immunohistochemical data were tabulated and statistically analyzed using one-way analysis of variance (ANOVA) to determine group differences Following that, Dunnett&#x2019;s post-hoc test was utilized to compare the control group to the test group. For the findings to be considered statistically significant, P had to be lower than 0.05. SPSS, version 11.0, was used for the collection and analysis of all statistical data. This software was developed by SPSS Inc. in Chicago, Illinois, in the United States of America.</p>
            </sec>
        </sec>
        <sec id="sec13" sec-type="results">
            <title>Results</title>
            <sec id="sec14">
                <title>Histological results</title>
                <p>The architecture of a standard SMG was revealed by the control group. The gland was formed of two main components; the stroma and the parenchyma. Serous acini and various duct types made up the parenchyma. The serous acini were small, rounded, and had narrow lumens. Each acinus is lined with pyramidal cells that have basophilic cytoplasm and large, basal spherical nuclei. Simple cuboidal epithelium with central rounded nuclei and little cytoplasm lining intercalated ducts. Columnar cells with open face nuclei lined the granular convoluted tubules, and the cytoplasm had eosinophilic granules. The striated ducts had high cubical or columnar cells with rounded nuclei and apical brush borders, and basal eosinophilic striations (
                    <xref ref-type="fig" rid="f2">Figure 2A</xref>). Examination of BoNT group revealed many changes in the SMG. Some acinar cells showed There are many cytoplasmic vacuoles, and there are different types of nuclear shape, size, and number. Other acinar cells had darkly stained cytoplasm and appeared lodged with retained secretory granules. Also, separation between acini was evident. The ducts revealed abnormal architecture, and many ductal cells exhibited cytoplasmic destruction and vacuolization (
                    <xref ref-type="fig" rid="f2">Figure 2B</xref>). Cells in the ducts and acini showed striking improvement in the BoNT + EGCG nanoemulsion group, in contrast to the BoNT group (
                    <xref ref-type="fig" rid="f2">Figure 2C</xref>).</p>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>Light photomicrographs of the SMG stained with H&amp;E stain.</title>
                    </caption>
                    <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/148664/18b75490-a2e8-42a3-a2c7-30953507a647_figure2.gif"/>
                </fig>
            </sec>
            <sec id="sec15">
                <title>Immunohistochemical results</title>
                <p>
                    <bold>
                        <italic toggle="yes">Bcl-2 immunohistochemical expression</italic>
                    </bold>
                </p>
                <p>In the control and BoNT + EGCG nanoemulsion groups, anti-Bcl-2 antibody staining of the cells was found to be weak to moderate. However, the BoNT group&#x2019;s cells were strongly stained (
                    <xref ref-type="fig" rid="f3">Figure 3A-C</xref>).</p>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Figure 3. </label>
                    <caption>
                        <title>Photomicrographs of Bcl-2 immunohistochemical-stained sections of the SMGs.</title>
                    </caption>
                    <graphic id="gr3" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/148664/18b75490-a2e8-42a3-a2c7-30953507a647_figure3.gif"/>
                </fig>
                <p>The BoNT group had more Bcl-2-positive immunostained cells than the control and BoNT + EGCG nanoemulsion groups, according to the statistical analysis (
                    <xref ref-type="fig" rid="f4">Figure 4</xref> &amp; 
                    <xref ref-type="table" rid="T1">Table 1</xref>).</p>
                <fig fig-type="figure" id="f4" orientation="portrait" position="float">
                    <label>Figure 4. </label>
                    <caption>
                        <title>Bar chart reveals the mean of Bcl-2 expression among the three groups.</title>
                    </caption>
                    <graphic id="gr4" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/148664/18b75490-a2e8-42a3-a2c7-30953507a647_figure4.gif"/>
                </fig>
                <table-wrap id="T1" orientation="portrait" position="float">
                    <label>Table 1. </label>
                    <caption>
                        <title>The mean &#x00b1; SD of BCL-2 among the different groups.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">BCL 2</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">BoNTA</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">EGCG nanoemulsion</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Control</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Range</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2&#x2013;5</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1&#x2013;3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1&#x2013;3</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Mean</bold> &#x00b1; 
                                    <bold>SD</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4.37 &#x00b1; 0.89</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.57 &#x00b1; 0.63</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.83 &#x00b1; 0.65</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>F. test</bold>
                                </td>
                                <td align="left" colspan="3" rowspan="1" valign="middle">134.044</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>P. value</bold>
                                </td>
                                <td align="left" colspan="3" rowspan="1" valign="middle">0.001*</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>BoNTA &amp; EGCG</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>BoNTA &amp; Control</bold>
                                </td>
                                <td align="left" colspan="2" rowspan="1" valign="middle">
                                    <bold>EGCG &amp; Control</bold>
                                </td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.001*</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.001*</td>
                                <td align="left" colspan="2" rowspan="1" valign="middle">0.161</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>
                    <bold>
                        <italic toggle="yes">E-cadherin immunohistochemical expression</italic>
                    </bold>
                </p>
                <p>Examination of E-cadherin immunoreactivity revealed moderate staining of cells in the control group, weak staining of cells in the BoNT group, and strong staining of cells in the BoNT + EGCG nanoemulsion group (
                    <xref ref-type="fig" rid="f5">Figure 5A-C</xref>).</p>
                <fig fig-type="figure" id="f5" orientation="portrait" position="float">
                    <label>Figure 5. </label>
                    <caption>
                        <title>Photomicrographs of E-Cadherin immunohistochemical-stained sections of the SMGs.</title>
                    </caption>
                    <graphic id="gr5" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/148664/18b75490-a2e8-42a3-a2c7-30953507a647_figure5.gif"/>
                </fig>
                <p>When compared to the control and BoNT groups, the E-cadherin positively immunostained cells of the BoNT + EGCG nanoemulsion group showed a significant increase, according to the statistical analysis of the data. The control group had more E-cadherin-positive immunostained cells than the BoNT group (
                    <xref ref-type="fig" rid="f6">Figure 6</xref> &amp; 
                    <xref ref-type="table" rid="T2">Table 2</xref>).</p>
                <fig fig-type="figure" id="f6" orientation="portrait" position="float">
                    <label>Figure 6. </label>
                    <caption>
                        <title>Bar chart reveals the mean of E-Cadherin expression among the three groups.</title>
                    </caption>
                    <graphic id="gr6" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/148664/18b75490-a2e8-42a3-a2c7-30953507a647_figure6.gif"/>
                </fig>
                <table-wrap id="T2" orientation="portrait" position="float">
                    <label>Table 2. </label>
                    <caption>
                        <title>The mean &#x00b1; SD of E-Cadherin among the different groups.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">E-Cadherin</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">BoNTA</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">EGCG nanoemulsion</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Control</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Range</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1&#x2013;3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">3&#x2013;5</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2&#x2013;5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Mean</bold> &#x00b1; 
                                    <bold>SD</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.47 &#x00b1; 0.63</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4.43 &#x00b1; 0.63</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">3.80 &#x00b1; 0.66</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>F. test</bold>
                                </td>
                                <td align="left" colspan="3" rowspan="1" valign="middle">178.802</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>P. value</bold>
                                </td>
                                <td align="left" colspan="3" rowspan="1" valign="middle">0.001*</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>BoNTA &amp; EGCG</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>BoNTA &amp; Control</bold>
                                </td>
                                <td align="left" colspan="2" rowspan="1" valign="middle">
                                    <bold>EGCG &amp; Control</bold>
                                </td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.001*</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.001*</td>
                                <td align="left" colspan="2" rowspan="1" valign="middle">0.001*</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
            <sec id="sec16">
                <title>Transmission electron microscopic results</title>
                <p>The SMG&#x2019;s normal ultrastructure was visible in the control group. Pyramidal cells with basal nuclei lined the acinar cells. RER parallel arrays were present in well-developed arrays at the base of the cells (
                    <xref ref-type="fig" rid="f7">Figure 7A</xref>). The epithelium lining the striated duct was simple and columnar in shape, characterized by round euchromatic nuclei, infolded basal membranes, and vertically arranged mitochondria (
                    <xref ref-type="fig" rid="f7">Figure 7B</xref>). The BoNT group SMG showed many degenerative changes. Acinar cells had many abnormally shaped secretory granules and RER (
                    <xref ref-type="fig" rid="f7">Figure 7C</xref>). The striated duct showed a loss of normal architecture, and the ductal cells exhibited cytoplasmic rarefaction, dispersed RER, and an abnormal distribution of abnormally configured mitochondria (
                    <xref ref-type="fig" rid="f7">Figure 7D</xref>). The ultrastructural findings in the BoNT + EGCG nanoemulsion group revealed marked improvement in the SMG compared to the BoNT group and showed nearly normal acini and striated ducts (
                    <xref ref-type="fig" rid="f7">Figure 7E</xref> &amp; 
                    <xref ref-type="fig" rid="f7">F</xref>).</p>
                <fig fig-type="figure" id="f7" orientation="portrait" position="float">
                    <label>Figure 7. </label>
                    <caption>
                        <title>Electron micrographs of the SMGs.</title>
                        <p>Control group I reveals normal shape of SMG.</p>
                    </caption>
                    <graphic id="gr7" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/148664/18b75490-a2e8-42a3-a2c7-30953507a647_figure7.gif"/>
                </fig>
            </sec>
        </sec>
        <sec id="sec17" sec-type="discussion">
            <title>Discussion</title>
            <p>BoNT is a novel treatment for many diseases, including salivary gland diseases. Treatment for sialorrhea has included the injection of BoNT into the salivary glands, which is thought to be a secure and minimally invasive procedure. Accidental injections may also occur into the SMG when treating facial wrinkles at the platysma or under the chin for cosmetic reasons. But there hasn&#x2019;t been enough research done on BoNT injection&#x2019;s negative effects (
                <xref ref-type="bibr" rid="ref12">Granja 
                    <italic toggle="yes">et al.</italic>, 2017</xref>). The current study produced some novel results and attempted to address the damaging effect of SMG injection of BoNT in rats and the capability of EGCG nanoemulsion to subside this harming effect.</p>
            <p>Rats were chosen as the study&#x2019;s preferred experimental model because of their resemblance to humans in terms of physiology, anatomy, and genetics. In addition to their small size, they have low maintenance requirements, a quick lifespan, ample genetic resources, accessibility, and an affordable price (
                <xref ref-type="bibr" rid="ref13">Tsai &amp; Chen, 2016</xref>).</p>
            <p>Control SMGs revealed normal histological structures devoid of significant histological and ultrastructural alterations in the serous acini and duct system. In rabbit SMGs injected with normal saline 
                <xref ref-type="bibr" rid="ref14">Chen 
                    <italic toggle="yes">et al.</italic> (2020)</xref>, found regular acinar and ductal cells without morphological changes. In BoNT-injected SMGs, some serous acini lost their spherical shape and had cytoplasmic vacuoles. In addition, the loss of basal striations and faulty borders in striated ducts were observed. These results agreed with those of 
                <xref ref-type="bibr" rid="ref16">Al-Allaf 
                    <italic toggle="yes">et al.</italic> (2022)</xref>. Whereas compared to controls, parotid glands treated with BoNT had smaller acinar cells and a wider striated duct lumen. These effects may be the result of glandular denervation brought on by the inhibition of soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors involved in acetylcholine release at the neuroglandular junction, particularly those involved in acinar cell granule exocytosis. Additionally (
                <xref ref-type="bibr" rid="ref17">Younis 
                    <italic toggle="yes">et al.</italic>, 2013</xref>), proposed that the molecular mechanism of action of BoNT involves inhibiting the muscarinic receptor (M3) and preventing the expression of aquaporin 5, which is involved in the secretion of water.</p>
            <p>In the current study, quantitative Bcl2 immunohistochemical expression in the BoNT group was significantly higher than in other groups. This discovery may be explained by the degenerative modifications and apoptosis brought on by BoNT in the SMG cells. Moreover, in this work, E-cadherin immunohistochemical expression in the BoNT group was significantly lower than that in other groups, indicating a decline in parenchymal cell adhesions. These findings matched previous research, which evidenced apoptosis and necrosis along with a reduction in the proliferative activity in SMG cells following BoNT intraglandular injection (
                <xref ref-type="bibr" rid="ref18">Regueira 
                    <italic toggle="yes">et al.</italic>, 2019</xref>; 
                <xref ref-type="bibr" rid="ref19">Oliveira 
                    <italic toggle="yes">et al.</italic>, 2017</xref>).</p>
            <p>Finally, while BoNT application clearly damages both histological and ultrastructural levels, the BoNT/EGCG nanoemulsion combination showed the least changes. So, as a minimally invasive treatment method for SMG hyperfunction, BoNT/EGCG nanoemulsion can be used in place of surgical intervention or duct ligation.</p>
            <sec id="sec18">
                <title>Authorships</title>
                <p>
                    <bold>Ahmed Abdelaziz Mohamed Essa:</bold> Conceptualization, Data Curation, Resources, Writing &#x2013; Original Draft Preparation, Writing &#x2013; Review &amp; Editing</p>
                <p>
                    <bold>Omneya Mohamed Wahba:</bold> Data Curation, Formal Analysis, Investigation, Methodology</p>
                <p>
                    <bold>Nahla Gamaeldin El-Helbawy:</bold> Data Curation, Methodology, Resources, Supervision, Visualization, Writing &#x2013; Review &amp; Editing</p>
                <p>
                    <bold>Ola M. El-Borady:</bold> Data Curation, Investigation, Methodology, Writing &#x2013; Original Draft Preparation, Writing &#x2013; Review &amp; Editing</p>
                <p>
                    <bold>Doaa Ahmed Labah:</bold> Data Curation, Formal Analysis, Investigation, Methodology, Writing &#x2013; Review &amp; Editing</p>
            </sec>
        </sec>
    </body>
    <back>
        <sec id="sec22" sec-type="data-availability">
            <title>Data availability</title>
            <p>Figshare. 
                <xref ref-type="bibr" rid="ref20">Essa, Ahmed (2023)</xref>: Effect of Epigallocatechin Gallate Figures and Figure legends. DOI: 
                <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.23055356">https://doi.org/10.6084/m9.figshare.23055356</ext-link> (
                <xref ref-type="bibr" rid="ref20">Essa, 2023</xref>).</p>
            <sec id="sec19">
                <title>Reporting guidelines</title>
                <p>Figshare. ARRIVE. DOI: 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.23691360.v1">https://doi.org/10.6084/m9.figshare.23691360.v1</ext-link>
                </p>
            </sec>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="ref16">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Al-Allaf</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mammdoh</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ahmed</surname>
                            <given-names>A</given-names>
                        </name>
</person-group>:
                    <article-title>The histologic effects of high doses of botulinum toxin a on the rabbit&#x2019;s salivary gland.</article-title>
                    <source>

                        <italic toggle="yes">Iraqi Journal of Veterinary Sciences.</italic>
</source>
                    <year>2022</year>;<volume>36</volume>(<issue>4</issue>):<fpage>1111</fpage>&#x2013;<lpage>1117</lpage>.
                    <pub-id pub-id-type="doi">10.33899/ijvs.2022.133149.2184</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bae</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kim</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shin</surname>
                            <given-names>Y</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Activity of catechins and their applications.</article-title>
                    <source>

                        <italic toggle="yes">Biomed Dermatol.</italic>
</source>
                    <year>2020</year>;<volume>4</volume>:<fpage>8</fpage>.
                    <pub-id pub-id-type="doi">10.1186/s41702-020-0057-8</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chan</surname>
                            <given-names>KH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Liang</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wilson</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.</article-title>
                    <source>

                        <italic toggle="yes">JAMA Otolaryngol. Head Neck Surg.</italic>
</source>
                    <year>2013</year>;<volume>139</volume>(<issue>2</issue>):<fpage>134</fpage>&#x2013;<lpage>138</lpage>.
                    <pub-id pub-id-type="doi">10.1001/jamaoto.2013.1328</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>BH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hsieh</surname>
                            <given-names>CH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tsai</surname>
                            <given-names>SY</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway.</article-title>
                    <source>

                        <italic toggle="yes">Sci. Rep.</italic>
</source>
                    <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>5163</fpage>.
                    <pub-id pub-id-type="pmid">32198390</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41598-020-62136-2</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7083948</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Eng</surname>
                            <given-names>QY</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Thanikachalam</surname>
                            <given-names>PV</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ramamurthy</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <article-title>Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.</article-title>
                    <source>

                        <italic toggle="yes">J. Ethnopharmacol.</italic>
</source>
                    <year>2018</year>;<volume>210</volume>:<fpage>296</fpage>&#x2013;<lpage>310</lpage>.
                    <pub-id pub-id-type="pmid">28864169</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jep.2017.08.035</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref20">
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Essa</surname>
                            <given-names>A</given-names>
                        </name>
</person-group>:
                    <article-title>Effect of Epigallocatechin Gallate Figures and Figure legends figshare.</article-title>
                    <source>

                        <italic toggle="yes">Figure.</italic>
</source>
                    <year>2023</year>.
                    <pub-id pub-id-type="doi">10.6084/m9.figshare.23055356</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Gadkari</surname>
                            <given-names>PV</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shashidhar</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Balaraman</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Delivery of green tea catechins through Oil-in-Water (O/W) nanoemulsion and assessment of storage stability.</article-title>
                    <source>

                        <italic toggle="yes">J. Food Eng.</italic>
</source>
                    <year>2017</year>;<volume>199</volume>:<fpage>65</fpage>&#x2013;<lpage>76</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.jfoodeng.2016.12.009</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Granja</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Frias</surname>
                            <given-names>I</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Neves</surname>
                            <given-names>AR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems.</article-title>
                    <source>

                        <italic toggle="yes">Biomed. Res. Int.</italic>
</source>
                    <year>2017</year>;<volume>2017</volume>:<fpage>5813793</fpage>.</mixed-citation>
            </ref>
            <ref id="ref5">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jayakeerthana</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <article-title>Benefits of Green Tea: A Review.</article-title>
                    <source>

                        <italic toggle="yes">J. Pharm. Sci. Res.</italic>
</source>
                    <year>2016</year>;<volume>8</volume>(<issue>10</issue>):<fpage>1184</fpage>&#x2013;<lpage>1187</lpage>.</mixed-citation>
            </ref>
            <ref id="ref3">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Karen</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Carlyn</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pieter</surname>
                            <given-names>H</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children with drooling due to central nervous system disorders.</article-title>
                    <source>

                        <italic toggle="yes">Dev. Med. Child Neurol.</italic>
</source>
                    <year>2017</year>;<volume>59</volume>(<issue>5</issue>):<fpage>531</fpage>&#x2013;<lpage>537</lpage>.</mixed-citation>
            </ref>
            <ref id="ref11">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Koutelidakis</surname>
                            <given-names>AE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Argyri</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sevastou</surname>
                            <given-names>Z</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Bioactivity of Epigallocatechin Gallate Nanoemulsions Evaluated in Mice Model.</article-title>
                    <source>

                        <italic toggle="yes">J. Med. Food.</italic>
</source>
                    <year>2017</year>;<volume>20</volume>(<issue>9</issue>):<fpage>923</fpage>&#x2013;<lpage>931</lpage>.
                    <pub-id pub-id-type="pmid">28737454</pub-id>
                    <pub-id pub-id-type="doi">10.1089/jmf.2016.0160</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Legeay</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rodier</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fillon</surname>
                            <given-names>L</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome.</article-title>
                    <source>

                        <italic toggle="yes">Nutrients.</italic>
</source>
                    <year>2015</year>;<volume>7</volume>(<issue>7</issue>):<fpage>5443</fpage>&#x2013;<lpage>5468</lpage>.
                    <pub-id pub-id-type="pmid">26198245</pub-id>
                    <pub-id pub-id-type="doi">10.3390/nu7075230</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4517007</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Musial</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kuban-Jankowska</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gorska-Ponikowska</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Beneficial Properties of Green Tea Catechins.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Mol. Sci.</italic>
</source>
                    <year>2020</year>;<volume>21</volume>(<issue>5</issue>):<fpage>1744</fpage>.
                    <pub-id pub-id-type="pmid">32143309</pub-id>
                    <pub-id pub-id-type="doi">10.3390/ijms21051744</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7084675</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref19">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Oliveira</surname>
                            <given-names>JB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ev&#x00ea;ncio-Neto</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Baratella-Ev&#x00ea;ncio</surname>
                            <given-names>L</given-names>
                        </name>
</person-group>:
                    <article-title>Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: Systematic Review.</article-title>
                    <source>

                        <italic toggle="yes">Braz. J. Biol.</italic>
</source>
                    <year>2017</year>;<volume>77</volume>(<issue>2</issue>):<fpage>251</fpage>&#x2013;<lpage>259</lpage>.</mixed-citation>
            </ref>
            <ref id="ref1">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pirazzini</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rossetto</surname>
                            <given-names>O</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Eleopra</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.</article-title>
                    <source>

                        <italic toggle="yes">Pharmacol. Rev.</italic>
</source>
                    <year>2017</year>;<volume>69</volume>(<issue>2</issue>):<fpage>200</fpage>&#x2013;<lpage>235</lpage>.
                    <pub-id pub-id-type="pmid">28356439</pub-id>
                    <pub-id pub-id-type="doi">10.1124/pr.116.012658</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5394922</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Regueira</surname>
                            <given-names>LS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Baratella-Ev&#x00ea;ncio</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Oliveira</surname>
                            <given-names>JB</given-names>
                            <prefix>de</prefix>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Effects of chronic treatment with botulinum toxin type A in salivary glands of rats: Histological and immunohistochemical analyses.</article-title>
                    <source>

                        <italic toggle="yes">J. Oral Pathol. Med.</italic>
</source>
                    <year>2019</year>;<volume>48</volume>(<issue>8</issue>):<fpage>728</fpage>&#x2013;<lpage>734</lpage>.
                    <pub-id pub-id-type="pmid">31141206</pub-id>
                    <pub-id pub-id-type="doi">10.1111/jop.12887</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sherif</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Esmail</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Abdelfattah</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Effects of Botulinum Toxin A (Botox) on cellular organs of Submandibular Salivary Gland in Rats (Ultrastructural study).</article-title>
                    <source>

                        <italic toggle="yes">Al-Azhar Journal of Dental Science.</italic>
</source>
                    <year>2018</year>;<volume>21</volume>(<issue>5</issue>):<fpage>503</fpage>&#x2013;<lpage>510</lpage>.
                    <pub-id pub-id-type="doi">10.21608/ajdsm.2018.71693</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Thenganatt</surname>
                            <given-names>MA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fahn</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <article-title>Botulinum Toxin for the Treatment of Movement Disorders.</article-title>
                    <source>

                        <italic toggle="yes">Curr. Neurol. Neurosci. Rep.</italic>
</source>
                    <year>2012</year>;<volume>12</volume>:<fpage>399</fpage>&#x2013;<lpage>409</lpage>.
                    <pub-id pub-id-type="doi">10.1007/s11910-012-0286-3</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tsai</surname>
                            <given-names>YJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>BH</given-names>
                        </name>
</person-group>:
                    <article-title>Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Nanomedicine.</italic>
</source>
                    <year>2016</year>;<volume>11</volume>:<fpage>1907</fpage>&#x2013;<lpage>1926</lpage>.
                    <pub-id pub-id-type="pmid">27226712</pub-id>
                    <pub-id pub-id-type="doi">10.2147/IJN.S103759</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Younis</surname>
                            <given-names>RE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Abou Elkhier</surname>
                            <given-names>MT</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mourad</surname>
                            <given-names>MI</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Ultrastructural changes in the parotid gland of rats after intraglandular injection of Botulinum toxin A.</article-title>
                    <source>

                        <italic toggle="yes">Ann. Oral Maxillofacial Surg.</italic>
</source>
                    <year>2013</year>;<volume>1</volume>(<issue>4</issue>):<fpage>38</fpage>.
                    <pub-id pub-id-type="doi">10.13172/2052-7837-1-4-1095</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report209240">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.148664.r209240</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Vacharaksa</surname>
                        <given-names>Anjalee</given-names>
                    </name>
                    <xref ref-type="aff" rid="r209240a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r209240a1">
                    <label>1</label>Department of Microbiology, Chulalongkorn University, Bangkok, Thailand</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>9</day>
                <month>10</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Vacharaksa A</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport209240" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.135540.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Experimental design 
                <list list-type="bullet">
                    <list-item>
                        <p>To observe the damaging effect of injection, another control should be added with normal buffer, without and chemical intervention. There is no detail on the Group I control if the animals in this group got a sham injection or not.</p>
                    </list-item>
                    <list-item>
                        <p>The authors should explain the rationale of not adding another control group with "only EGCG injection".</p>
                    </list-item>
                    <list-item>
                        <p>The authors should explain the rationale of giving EGCG nanoemulsions in a once-daily dose of 0.1&#x2009;ml by oro-gastric intubation.</p>
                    </list-item>
                </list> </p>
            <p> Details of methods and analysis 
                <list list-type="bullet">
                    <list-item>
                        <p>Number of animals of each experimental group should be clearly written in text, and displayed in the figure.</p>
                    </list-item>
                    <list-item>
                        <p>Group III (BoNT + EGCG nanoemulsion group) should be written in the figure legend, not just "EGCG nanoemulsion".</p>
                    </list-item>
                    <list-item>
                        <p>Some data can be analyzed quantitatively, including Table 1 and 2. However, normal distribution of the data should be demonstrated before selecting parametric analysis. The statistical comparison should be displayed in the figure, rather than adding tables of statistic analysis.</p>
                    </list-item>
                </list> </p>
            <p> Discussion and conclusions 
                <list list-type="bullet">
                    <list-item>
                        <p>The original purpose of this study remains unclear in discussion. It is confused whether the injection of BoNT is necessary for a therapeutic purpose. If EGCG can reduce the damage, the effect of EGCG on therapeutic purpose of BoNT should be discussed.</p>
                    </list-item>
                    <list-item>
                        <p>Tissue damage by the injection technique should be discussed.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>There is not statement why an "albino" rat was chosen as a model. The aim of this study could be concluded with other rat models?</p>
                    </list-item>
                    <list-item>
                        <p>There is no discussion (only one sentence with no detail) on the benefits of adding EGCG.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Partly</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Partly</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Tissue regeneration in rat models</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
</article>
